Heart health and development in infants with liver disease
Part of Digestive system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at how common heart problems are in infants under 2 years old who have a type of liver disease called cholestasis. It also checks their development to see if these issues are linked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is younger than 2 years old.
- Your baby has been diagnosed with cholestasis (a liver condition that causes yellowing of the skin or eyes).
- Your baby was not born prematurely (before 37 weeks of pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how common liver problems are in children with congenital heart disease. It may help doctors better monitor and care for your child's liver health.
This study measures how well blood flows to the brain in infants with serious heart defects. The results may help doctors understand and protect brain development before and after heart surgery.
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
This study looks at how a mother's mental health during pregnancy may affect the brain development of babies with a serious heart condition called critical cyanotic congenital heart disease (CHD). It aims to understand this link to improve support for families.
This study looks at heart health in children under 18 who have long-term liver disease. It aims to understand what heart issues may occur, so doctors can better monitor and help these children.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.